𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia

✍ Scribed by Deborah A. Thomas; Andreas H. Sarris; Jorge Cortes; Stefan Faderl; Susan O'Brien; Francis J. Giles; Guillermo Garcia-Manero; Maria A. Rodriguez; Fernando Cabanillas; Hagop Kantarjian

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
93 KB
Volume
106
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II study of topotecan with vincr
A phase II study of topotecan with vincristine and doxorubicin in children with recurrent/refractory neuroblastoma
✍ Alberto Garaventa; Roberto Luksch; Simona Biasotti; Gianluca Severi; Maria Rosa πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 1 views

## Background: A phase ii trial in children with advanced neuroblastoma was carried out in five italian institutions to evaluate the antitumor activity and tolerability of topotecan followed by vincristine and doxorubicin. ## Methods: Children older than age 1 year with stage iii or stage iv neur

Combination therapy with methotrexate, v
Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia
✍ Alvaro Aguayo; Jorge Cortes; Deborah Thomas; Sherry Pierce; Michael Keating; Hag πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 72 KB πŸ‘ 2 views

BACKGROUND. L-asparaginase in combination with methotrexate has synergistic antileukemic activity in a schedule-dependent fashion. A new preparation of L-asparaginase, polyethylene-glycol conjugated (PEG)-asparaginase, is a pharmacologically different formulation of L-asparaginase with distinct prop

A phase II and pharmacodynamic study of
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer
✍ Edwin M. Posadas; Meghan S. Liel; Virginia Kwitkowski; Lori Minasian; Andrew K. πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 145 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The primary objective of this study was to evaluate the biochemical effects of gefitinib on its target signal‐transduction pathways in patients with recurrent epithelial ovarian cancer (EOC). The secondary objectives included assessing clinical activity and toxicity and d